For information about other calls and webinars related to COVID-19, please visit our COVID-19 Resource Page

For other upcoming events, visit Events.

Archived Webinars

According to the CDC, the percentage of individuals in the U.S. living with obesity reached 42.5% in 2018. Individuals who live with obesity are at greater risk for many other serious chronic diseases, including severe illness and death from COVID-19. Our speakers will explore the multifaceted obesity crisis, including its relevance to health disparities, and the role of research and development. Watch the recording here.

COVID-19 treatments exemplify the significance of the public-private sector R&D continuum. While these treatments have not generally received the same level of attention as vaccines, they are critical to our response to the pandemic. This panel discussion explores the range of treatments available; how, when, and in what settings they are administered; and ways to ensure these treatments reach patients in need. Watch the recording here.







RNA interference (RNAi) is a scientific breakthrough that, thanks to the determination of both academic and industry researchers, is empowering desperately needed progress against rare diseases. Global health threats like COVID-19 have further demonstrated the significance of this innovative platform. The Research!America briefing, From Nobel Winning Science to Next Generation Treatment: Tracing the Path of a Rare Disease Breakthrough using RNAi, included a discussion focusing on the influence of RNAi technology on medical progress. Moderated by Dr. Elias Zerhouni, participants Isabelle Lousada, president & CEO, Amyloidosis Research Consortium, Dr. Philip Sharp, institute professor, and professor of Biology, MIT, Dr. Akshay Vaishnaw, president of Research & Development at Alnylam Pharmaceuticals, and Brian Zambrowicz, senior vice president of Functional Genomics and Chief VelociGene® Operations at Regeneron Pharmaceuticals explored the impact of RNAi technology in addressing unmet medical needs and demonstrated the symbiotic roles of the public and private sectors.

Watch the recorded briefing here. 

Check out the infographic here.


Journalist and political analyst Frank Sesno, former CNN Washington Bureau Chief and anchor, and Director of The George Washington University’s School of Media and Public Affairs, was joined by Georges Benjamin, MD, Executive Director, American Public Health Association in a conversation moderated by Jenny Luray, Research!America Vice President of Strategy and Communications. What do the election results tell us about the policy outlook for science, medical research, and public health? Cybele Bjorklund, Vice President, Federal Strategy for Johns Hopkins University and Red Maple Consulting’s Pete Kirkham rounded out the briefing with a look at opportunities and challenges during the lame duck 116th Congress including supplemental funding and appropriations -- and what lies ahead for the 117th.

Watch the recorded webinar here. 


How is COVID-19 affecting progress against cancer and other long-standing health threats? This virtual roundtable discussion explored the impact of the COVID-19 pandemic on public and private sector-fueled medical progress. The panelists discussed the pandemic’s influence on the research NIH conducts and supports, our nation’s R&D infrastructure, the private sector investment climate, technology transfer and other key variables influencing the pace of medical progress, and opportunities to quickly reboot R&D as we move forward.

Watch the recorded webinar here. 

Download the Biomedical Research and Development Pipeline infographic.


This webinar provided a high-level overview of the most promising scientific approaches underway to create vaccines, treat COVID-19 symptoms, cure serious cases, and prevent infection. View the recording and other resources here.


Connecting the Dots: What Will it Take To Meet the Challenge of Migraine?

Original air date: December 11, 2018

Featuring: Suchitra Iyer, PhDCenter for Evidence and Practice Improvement, Agency for Healthcare Research and Quality; Alicia TorborgExecutive Director for the Association of Migraine Disorders, Migraine Patient; and Lindsay Videnieks, JDExecutive Director of the Headache and Migraine Policy Forum (HMPF)

During the webinar, panelists discussed the challenges of access to treatment, access to migraine specialists, and the state of research on migraine treatment as well as broader topics of pain management. 

Click here to view a recording of the webinar. 



The Value of Evidence-Based Treatments for Migraine Sufferers

Original air date: June 12, 2018

Featuring: Dr. Lisa DeLeonardolicensed psychologist and migraine patientDr. Peter McAllister, medical director, New England Institute for Neurology and Headache, chief medical officer, New England Institute for Clinical Research and Ki Clinical Research; and Dr. Jan Lewis Brandesfounder, Nashville Neuroscience Group and assistant clinical professor, Department of Neurology, Vanderbilt University School of Medicine

During this webinar, experts discussed how advances in research have addressed gaps in migraine prevention and treatment, and development of new therapies. They also talked about efforts to improve access to care for migraine patients.

Click here to view a recording of the webinar.

Webinar: Measuring Advocacy Outcomes

Original air date: June 1, 2018

Featuring: The Honorable Bart Gordon, partner, K&L Gates LLP, U.S. Representative, 1985-2011Carlisle Levine, Ph.D., president and CEO of BLE Solutions in Arlington, VAAnnette L. Gardner, Ph.D., MPH, assistant professor, Philip R. Lee Institute for Health Policy Studies at the University of California, San Francisco

This webinar explored ways to gauge performance against short- and long-term advocacy goals, manage expectations, and identify gaps in science advocacy metrics. Speakers touched on how to evaluate public opinion survey data about support for science and tailor your advocacy messages and approaches in light of that data.

Click here to view a recording of the webinar.

Inspiring Others to be Science Advocates

Original air date: April 18, 2018

Featuring: Monica Linden, Ph.D., senior lecturer at Brown UniversityCynthia Gibbs, founder and director of Science Pub RVARick Karnesky, Ph.D., co-boss, Nerd Nite East Bay

Research!America and the Society for Neuroscience hosted a webinar on April 18 during which expert advocates discussed creative ways to attract nonscientific audiences to events. Speakers provided insights on how to inspire scientist peers and nonscientists to engage in advocacy and outreach in support of science. Through participating in public activities such as Science Pub and Nerd Nite, holding informal coffee meetings with your colleagues, and partaking in other activities, you can empower others to get involved.

Click here to view a recording of the webinar. 

What Are The Barriers in Advancing Migraine Research?

Original air date: April 11, 2018

Featuring: Michael L. Oshinsky, Ph.D., program director, pain and migraine, NINDS/NIHRobert E. Shapiro, M.D., Ph.D., Department of Neurological Sciences, Larner College of Medicine at the University of VermontKatie M. Goldenprofessional migraine patient

Nearly one in four U.S. households include someone with migraine. Despite the prevalence of this neurological disease, few effective treatments are available for patients. It is critical for researchers to understand the causes of migraine to increase the opportunity to develop and test interventions that could be more targeted to preventing or interrupting attacks, according to the National Institutes of Health. How can we ensure the right treatment reaches the patient at the right time?

This webinar focused on prevention, research, and discoveries in treatment and therapies for migraine.

Click here to view a recording of the webinar.

Strategies to Maximize Your Advocacy Results

Original air date: February 23, 2018

Featuring: Sudip S. Parikh, Ph.D., senior vice president & managing director, DIA Americas, and Research!America board member; Pete Kirkham, president and founder of Red Maple Consulting; Lori L. McMahon Wakefield, Ph.D., dean, UAB Graduate School, Jarman F. Lowder Professor of Neuroscience, director, Comprehensive Neuroscience Center, University of Alabama at Birmingham

Speakers provide science advocates with timely and relevant information on how to best prepare for Capitol Hill meetings and tailor messages for the current political environment.

Click here to view a recording of the webinar. 

Leveraging Public Opinion in Support of Science

Original air date: December 4, 2017

Featuring: Mary Woolley, president and CEO, Research!America; Christopher Volpe, Ph.D., executive director, ScienceCounts; and Navneet Matharu, Ph.D., postdoctoral fellow, University of California San Francisco

Public support of science can be instrumental in influencing congressional support of research funding. While public support for science is strong, few Americans understand our nation’s scientific enterprise. Speakers provide tips for effectively communicating about the importance of science, the patient experience, and recent discoveries that have potential policy implications to increase public support of federally-funded scientific research. 

Click here to view a recording of the webinar. 

Innovative Research and the Opioid Epidemic: Are We Closer to Finding Solutions?

Original air date: October 13, 2017

Featuring: Nora Volkow, M.D., Director, National Institute on Drug Abuse at the National Institutes of Health; Georges Benjamin, M.D., Executive Director, American Public Health Association; and Jeffrey Bratberg, Pharm.D., Clinical Professor, University of Rhode Island College of Pharmacy

As the opioid epidemic continues to intensify, innovative scientific solutions provide much needed hope to alleviate the suffering of the tens of thousands of Americans. Experts discuss the role of research, implications for public health and the role of pharmacists in addressing the crisis. 

To learn more: view the slides and watch a recording of the webinar. 

The Fogarty International Center: How Americans Benefit from Global Health Research

Original air date: May 25, 2017

Sponsored by: the Infectious Diseases Society of America, the American Society of Tropical Medicine and Hygiene, and Research!America

Featuring: Roger Glass, M.D., Ph.D., Director of The Fogarty International Center at NIH; Chris Beyrer, M.D., MPH, Johns Hopkins Bloomberg School of Public Health; Bob Bollinger, M.D., MPH, Johns Hopkins Bloomberg School of Public Health; and Christine Lubinski, Vice President for Global Health Infectious Diseases Society of America (IDSA)

“Diseases Know No Borders” – investment in prevention and infrastructure is vital to protecting future generations from outbreaks such as Ebola and Zika. Did you know that 80% of the funding for global health initiatives goes to scientists and institutions right here in the U.S.? The rest is invested in creating sustainable platforms for containing outbreaks before they reach the U.S.

To learn more: watch the webinar here.

The Microbiome Initiative: A Closer Look 

Original air date: September 16, 2016

Sponsored by: the American Society for Microbiology and Research!America

Featuring: Dr. Stefano Bertuzzi, Executive Director and CEO of the American Society for Microbiology

Microbiomes live on or in people, plants, soil, oceans, and the atmosphere. How do they affect human health? The National Microbiome Initiative (NMI) is a collaborative effort by federal agencies and private-sector stakeholders to support research, develop technology, and expand the microbiome workforce. Innovative breakthroughs in health, technology, environmental science, and biofuels are on the horizon.

To learn more: watch the webinar here.

Media Contacts

Tim Haynes
Senior Director of Communications 

Without research, there is no hope.
The Honorable Paul G. Rogers